Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1432.60 18.85 (1.33%) | NSE 1439.80 25.10 (1.77%) | Trade | Add

BSE Live

Dec 26, 16:01

1432.60 18.85 (1.33%)

Volume

AVERAGE VOLUME

5-Day

3,828

10-Day

4,581

30-Day

37,665

4,584

Prev. Close

1413.75
Open Price

1415.25

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 26, 15:57

1439.80 25.10 (1.77%)

Volume

AVERAGE VOLUME

5-Day

95,136

10-Day

113,016

30-Day

374,069

99,953

Prev. Close

1414.70
Open Price

1420.40

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1439.80 (198)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Ipca Laboratories (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Per Share Ratios
Basic EPS (Rs.)	35.14	25.82	18.58	34.85	45.01
Diluted EPS (Rs.)	29.08	21.57	18.58	34.85	45.01
Cash EPS (Rs.)	46.72	34.94	29.70	45.07	107.06
Book Value [ExclRevalReserve]/Share (Rs.)	273.88	304.57	233.16	219.51	371.79
Book Value [InclRevalReserve]/Share (Rs.)	273.88	304.57	233.16	219.51	371.79
Revenue from Operations/Share (Rs.)	352.37	303.71	246.13	229.79	427.28
PBDIT/Share (Rs.)	71.70	56.99	41.48	54.23	126.70
PBIT/Share (Rs.)	56.02	42.91	31.17	45.07	110.21
PBT/Share (Rs.)	44.59	33.22	29.38	44.77	109.50
Net Profit/Share (Rs.)	31.04	20.86	19.39	35.91	90.57
NP After MI And SOA / Share (Rs.)	29.08	21.57	18.58	34.85	89.87
Profitability Ratios
PBDIT Margin (%)	20.34	18.76	16.85	23.59	29.65
PBIT Margin (%)	15.89	14.12	12.66	19.61	25.79
PBT Margin (%)	12.65	10.93	11.93	19.48	25.62
Net Profit Margin (%)	8.80	6.86	7.87	15.62	21.19
NP After MI And SOA Margin (%)	8.25	7.10	7.54	15.16	21.03
Return on Networth/Equity (%)	10.61	8.64	8.06	16.09	24.24
Return on Capital Employed (%)	15.15	12.44	11.59	18.52	28.48
Return on Assets (%)	6.27	4.93	5.46	11.57	18.78
Total Debt/Equity (X)	0.19	0.22	0.25	0.14	0.05
Asset Turnover Ratio (%)	0.78	0.78	0.77	0.80	0.91
Liquidity Ratios
Current Ratio (X)	2.63	2.35	2.87	3.04	2.96
Quick Ratio (X)	1.55	1.30	1.91	1.77	1.59
Inventory Turnover Ratio (X)	3.55	1.05	0.95	0.96	1.10
Dividend Payout Ratio (NP) (%)	13.75	9.27	21.53	11.47	8.90
Dividend Payout Ratio (CP) (%)	8.93	5.60	13.84	9.08	7.52
Earnings Retention Ratio (%)	86.25	90.73	78.47	88.53	91.10
Cash Earnings Retention Ratio (%)	91.07	94.40	86.16	90.92	92.48
Coverage Ratios
Interest Coverage Ratios (%)	21.42	10.46	23.11	178.91	177.79
Interest Coverage Ratios (Post Tax) (%)	21.42	10.46	23.11	178.91	177.79
Valuation Ratios
Enterprise Value (Cr.)	40,485.27	33,899.87	20,234.90	27,148.88	24,038.82
EV/Net Operating Revenue (X)	4.53	4.40	3.24	4.66	4.44
EV/EBITDA (X)	22.26	23.45	19.23	19.73	14.96
MarketCap/Net Operating Revenue (X)	4.26	4.08	3.29	4.62	4.45
Retention Ratios (%)	86.24	90.72	78.46	88.52	91.09
Price/BV (X)	5.48	4.96	3.52	4.90	5.13
Price/Net Operating Revenue	4.26	4.08	3.29	4.62	4.45
Earnings Yield	0.02	0.02	0.02	0.03	0.05